Terms of Use
Gilead Sciences, Inc., ("Gilead") maintains the TRUVADA Web site as a service to the Internet community. The TRUVADA Web site has been designed to provide general information about Gilead and its products designed for the treatment of HIV and AIDS-related illnesses. These pages are not intended to provide investment or medical advice, nor do they provide instruction on the appropriate use of products produced or supplied under development by Gilead, its affiliates, related companies or its licensors or joint venture partners. Information on this Web site regarding products approved for marketing is qualified in its entirety by reference to the full prescribing information for products. Users of this Web site should be aware that products under development described herein have not been found safe or effective by any regulatory agency and are not approved for any use outside of clinical trials. Access and use of the TRUVADA Web site is subject to the terms and conditions set forth herein and all applicable laws, statutes and/or regulations. Gilead may revise these terms and conditions from time to time without further notice by updating this posting.
Gilead will use reasonable efforts to include accurate and up-to-date information on the TRUVADA Web site, but Gilead makes no warranties or representations as to the accuracy of information presented on the TRUVADA Web site. In addition, any information presented on the Web site as of a particular date may only be accurate as of such date and Gilead disclaims any responsibility to update such information. Gilead shall not be held responsible for any action taken that is based on the information presented on the TRUVADA Web site and all users of the TRUVADA Web site agree that all access and use of the TRUVADA Web site and any and all content presented on the TRUVADA Web site, is at the user's own risk. Neither Gilead nor any party involved in creating, producing or delivering this site shall be liable for any direct, incidental, consequential, indirect or punitive damages arising out of user's access, use or inability to use the TRUVADA Web site, or any errors or omissions in the content of the TRUVADA Web site. Any communication or material you transmit to Gilead via the TRUVADA Web site or Internet electronic mail is transmitted by you on a nonconfidential basis. Gilead makes no promise, express or implied, not to use such communication or material for any purpose whatsoever, including reproduction, publication, broadcast and posting.
It is the policy of Gilead to enforce its intellectual property rights to the fullest extent permitted under law. All product names, regardless of whether or not they appear in large print or with a trademark symbol, are trademarks of Gilead, its affiliates, related companies or its licensors or joint venture partners, unless otherwise noted. The entire content of the TRUVADA Web site, including any images or text, is copyrighted and may not be distributed, downloaded, modified, reused, reposted or otherwise used except as provided herein without the express written permission of Gilead. The use or misuse of these trademarks, copyrights or other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, communications regulations and statutes and other laws, statutes and/or regulations.
Note on forward-looking information: Except for the historical information contained herein, this Web site contains forward-looking statements, the accuracy of which are necessarily subject to known and unknown risks and uncertainties.
Patients should read the Patient Information, including "What is the most important information I should know about TRUVADA?". It is important that you discuss your treatment options and any questions that you may have with your healthcare provider.
Please read the Full Prescribing Information for TRUVADA, EMTRIVA, and VIREAD, including Boxed WARNINGS.
Please read the Full Prescribing Information for TRUVADA, ATRIPLA, EMTRIVA, and VIREAD, including Boxed WARNINGS.
*Synovate Healthcare Data; U.S. HIV Monitor, Q3, 2009.